Trials / Completed
CompletedNCT04544254
Effectivity of Bilateral Transversus Thoracis Muscle Plane Block After Open Heart Surgery
Effectivity of Bilateral Transversus Thoracis Muscle Plane Block to Reduce Pain and Stress Response After Open Heart Surgery: A Study to Interleukin-6 and Cortisol Plasma Concentration, Total Opioid Dose, and Time to First Opioid
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Indonesia University · Academic / Other
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This Study aimed to assess The Effectivity of Bilateral Transversus Thoracis Muscle Plane Block to Reduce Pain and Stress Response After Open Heart Surgery
Detailed description
This is a double blind randomized controlled trial. Thirty-two subject will be recruited with non-probability consecutive sampling method. Subjects who meet all inclusion criteria and do not have exclusion criteria will be asked to sign the informed consent form before included in this study. Subjects will be randomized into two groups. The first group is the treatment group who will get Bilateral Transversus Thoracis Muscle Plane Block after induction of anesthesia and the second group will be the control group who will not get any regional block during surgery. After surgery, time to first morphine dose, total morphine consumption in 24 hours, extubation time, and adverse events will be recorded for both group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Bilateral transversus thoracis muscle plane block | The block will be performed in between intercostal space 4 and 5, lateral from sternum, with ultrasound guided. Twenty milliliters bupivacaine 0.5% 1mg/body weight will be injected between internal intercostal muscle and transversus thoracis muscle on both sides. |
| PROCEDURE | Control | A needle will be place in the similar area to the transversus thoracis muscle plane block, but no drugs will be injected to the area |
Timeline
- Start date
- 2020-10-15
- Primary completion
- 2021-03-15
- Completion
- 2021-03-15
- First posted
- 2020-09-10
- Last updated
- 2021-11-08
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT04544254. Inclusion in this directory is not an endorsement.